Skip to content
Logo@2x
Asset 1@10x 1@2x
  • Company
  • Pipeline
  • News and Events
  • Careers
  • Contact Us
  • Company
  • Pipeline
  • News and Events
  • Careers
  • Contact Us

News and Events

    News
    Algok Bio and Institute of Cancer Research (ICR) Launch Phase 1b Trial of Idetrexed with PARP Inhibitor Lynparza for Ovarian Cancer

    March 1, 2025

    News
    Algok Bio Enters into Exclusive Worldwide License Agreement with BTG to Develop and Commercialize Idetrexed, a Clinical-Stage Folate Receptor-Targeted Oncology Drug

    April 11, 2023

logo-footer@2x

320 120th Ave. NE #208
Bellevue, Washington 98005, USA

+1-425-598-2107

9am–5:30pm Pacific Time

[email protected]
Company
Pipeline
Contact Us
News and Events
Careers
LinkedIn

Copyright © 2020-2025 Algok Bio Inc. All rights reserved.

Privacy Policy

Life Science Web Design by Supreme